VoxlBio, a KI Innovations DRIVE incubator company, introduces a groundbreaking targeted sequence-capture approach that preserves spatial context while delivering unparalleled sensitivity and specificity. This novel in situ genetic visualization technology enables direct detection of gene expression and single-nucleotide mutations within intact tissue at single-cell resolution. This platform opens new opportunities in advanced diagnostics, targeted therapy development, and fundamental disease research.